Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality. / Linneberg, Allan; Jacobsen, Rikke Kart; Jespersen, Lasse; Abildstrøm, Steen Z.

I: Journal of Allergy and Clinical Immunology, Bind 129, Nr. 2, 2012, s. 413-9.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Linneberg, A, Jacobsen, RK, Jespersen, L & Abildstrøm, SZ 2012, 'Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality', Journal of Allergy and Clinical Immunology, bind 129, nr. 2, s. 413-9. https://doi.org/10.1016/j.jaci.2011.09.007

APA

Linneberg, A., Jacobsen, R. K., Jespersen, L., & Abildstrøm, S. Z. (2012). Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality. Journal of Allergy and Clinical Immunology, 129(2), 413-9. https://doi.org/10.1016/j.jaci.2011.09.007

Vancouver

Linneberg A, Jacobsen RK, Jespersen L, Abildstrøm SZ. Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality. Journal of Allergy and Clinical Immunology. 2012;129(2):413-9. https://doi.org/10.1016/j.jaci.2011.09.007

Author

Linneberg, Allan ; Jacobsen, Rikke Kart ; Jespersen, Lasse ; Abildstrøm, Steen Z. / Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality. I: Journal of Allergy and Clinical Immunology. 2012 ; Bind 129, Nr. 2. s. 413-9.

Bibtex

@article{9585561728cf45a7afed8a8bcc7de3d8,

title = "Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality",

abstract = "Subcutaneous allergen-specific immunotherapy (SCIT) is a well-documented treatment of IgE-mediated allergic disease. Little is known about potential effects of SCIT on the risk of other chronic immune-related diseases. Over the years, a few casuistic reports have caused concern that SCIT might act as a trigger of autoimmune disease.",

author = "Allan Linneberg and Jacobsen, {Rikke Kart} and Lasse Jespersen and Abildstr{\o}m, {Steen Z}",

year = "2012",

doi = "http://dx.doi.org/10.1016/j.jaci.2011.09.007",

language = "English",

volume = "129",

pages = "413--9",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "2",

}

RIS

TY - JOUR

T1 - Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality

AU - Linneberg, Allan

AU - Jacobsen, Rikke Kart

AU - Jespersen, Lasse

AU - Abildstrøm, Steen Z

PY - 2012

Y1 - 2012

N2 - Subcutaneous allergen-specific immunotherapy (SCIT) is a well-documented treatment of IgE-mediated allergic disease. Little is known about potential effects of SCIT on the risk of other chronic immune-related diseases. Over the years, a few casuistic reports have caused concern that SCIT might act as a trigger of autoimmune disease.

AB - Subcutaneous allergen-specific immunotherapy (SCIT) is a well-documented treatment of IgE-mediated allergic disease. Little is known about potential effects of SCIT on the risk of other chronic immune-related diseases. Over the years, a few casuistic reports have caused concern that SCIT might act as a trigger of autoimmune disease.

U2 - http://dx.doi.org/10.1016/j.jaci.2011.09.007

DO - http://dx.doi.org/10.1016/j.jaci.2011.09.007

M3 - Journal article

VL - 129

SP - 413

EP - 419

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2

ER -

ID: 40217623